title: Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies.
authors.affiliation: aDivision of Infectious Diseases, Department of Internal Medicine San Gerardo Hospital, University of Milan-Bicocca bUOS Aferesi e nuove tecnologie trasfusionali- SIMT cHaematology Institute, 'San Gerardo' Hospital, University of Milan-Bicocca, Monza, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bandera
authors.forename: Luisa
authors.initials: L
authors.lastname: Verga
authors.forename: Paolo
authors.initials: P
authors.lastname: Perseghin
authors.forename: Arianna
authors.initials: A
authors.lastname: Incontri
authors.forename: Pietro E
authors.initials: PE
authors.lastname: Pioltelli
authors.forename: Andrea
authors.initials: A
authors.lastname: Gori
mesh_terms: D001596:Benzylamines; D000080027:Cyclams; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy*; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006571:Heterocyclic Compounds / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
chemical_list: D001596:Benzylamines; C527276:CXCR4 protein, human; D000080027:Cyclams; D006571:Heterocyclic Compounds; D019718:Receptors, CXCR4; C088327:plerixafor